Kefer John C, Voelzke Bryan B, Flanigan Robert C, Wojcik Eva M, Waters W Bedford, Campbell Steven C
Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA.
Urology. 2005 Dec;66(6):1251-5. doi: 10.1016/j.urology.2005.07.006.
To assess our clinical ability to predict prostate involvement by transitional cell carcinoma (PI-TCC) or occult prostate cancer (CAP) in patients undergoing radical cystectomy (RCx).
We retrospectively analyzed 70 male patients undergoing RCx for TCC of the bladder between 1995 and 2003, focusing on preoperative factors to predict PI-TCC or CAP.
Of 70 RCx patients, 30 (43%) had PI-TCC (14) or CAP (16). Risk factors for PI-TCC included carcinoma in situ, multifocal TCC, and bladder neck involvement (P <0.05 for all three analyses). All 14 patients with PI-TCC had one or more risk factors, and none of 40 patients without these risk factors had PI-TCC (P <0.001). Risk factors for CAP included elevated prostate-specific antigen level, abnormal results on digital rectal examination, and age more than 65 years. Of 16 patients with CAP, 14 had one or more of these risk factors (P <0.05). Sixteen of the seventy patients in this series (22.9%) had no risk factors for PI-TCC or CAP, and none of these had prostatic involvement with either malignancy (P <0.05).
Our findings suggest that a well-defined subset of patients undergoing RCx might be at low risk for malignancy in the prostate. However, further evaluation of these risk factors in a prospective setting will be required to substantiate these findings and guide clinical decision making in this controversial field.
评估我们预测接受根治性膀胱切除术(RCx)患者发生移行细胞癌前列腺侵犯(PI-TCC)或隐匿性前列腺癌(CAP)的临床能力。
我们回顾性分析了1995年至2003年间因膀胱移行细胞癌接受RCx的70例男性患者,重点关注预测PI-TCC或CAP的术前因素。
70例接受RCx的患者中,30例(43%)发生PI-TCC(14例)或CAP(16例)。PI-TCC的危险因素包括原位癌、多灶性TCC和膀胱颈受累(所有三项分析P<0.05)。所有14例PI-TCC患者均有一个或多个危险因素,40例无这些危险因素的患者均未发生PI-TCC(P<0.001)。CAP的危险因素包括前列腺特异性抗原水平升高、直肠指检结果异常和年龄超过65岁。16例CAP患者中,14例有一个或多个这些危险因素(P<0.05)。本系列70例患者中有16例(22.9%)无PI-TCC或CAP的危险因素,且这些患者均无前列腺恶性肿瘤侵犯(P<0.05)。
我们的研究结果表明,接受RCx的特定患者亚组可能前列腺恶性肿瘤风险较低。然而,需要在前瞻性研究中进一步评估这些危险因素,以证实这些发现并指导这一有争议领域的临床决策。